The new Fellows have been elected to the Academy in recognition of their exceptional contributions to the advancement of biomedical and health science, cutting edge research discoveries, and translating developments into benefits for patients and wider society.
The new Oxford Fellows are among the 54 new Fellows announced this year and will be formally admitted to the Academy at a ceremony on Wednesday 9 July 2025.
This recognition reflects the collaborative work of outstanding colleagues, students and collaborators with whom I have worked over the last two decades. - Professor Charalambos Antoniades
Professor Charalambos Antoniades FMedSci is British Heart Foundation Chair of Cardiovascular Medicine, Director of the Acute Multidisciplinary Imaging and Interventional Centre (AMIIC), Deputy Head of the Division of Cardiovascular Medicine and Professor of Cardiovascular Medicine.
Professor Antoniades studies the mechanisms by which different adipose tissue depots in the human body affect vascular and myocardial redox state in atherosclerosis, as well as searching for novel therapeutic strategies targeting vascular and myocardial redox signalling directly or through changes in the crosstalk between adipose tissue and cardiovascular system. He said:
'I am honoured to have been elected to the Academy of Medical Sciences. This recognition reflects the collaborative work of outstanding colleagues, students and collaborators with whom I have worked over the last two decades, and the support of the University of Oxford and the British Heart Foundation who funded my research programme during these years. I remain committed to research that advances cardiovascular care and improves patient outcomes in the UK and beyond.'
Professor Andrew Morris CBE FRSE PMedSci, President of the Academy of Medical Sciences, said: 'It is a privilege to welcome these 54 exceptional scientists to our Fellowship. Each new Fellow brings unique expertise and perspective to addressing the most significant health challenges facing society. The breadth of disciplines represented in this year's cohort – from mental health and infectious disease to cancer biology and respiratory medicine – reflects the rich diversity of medical science today. Their election comes at a crucial time when scientific excellence and collaboration across disciplines are essential for addressing global health challenges both now and in the future. We look forward to working with them to advance biomedical research and create an environment where the best science can flourish for the benefit of people everywhere.'